Induced pluripotent stem cell (IPSC)–based methods have become important research tools for developmental biology and molecular medicine. Reprogramming of somatic cells of either healthy or diseased individuals by the application of specific transgenes results in pluripotent and self-renewable cell lines that can be used to generate different cell types in vitro while still maintaining the genetic architecture of the donor.
The prospect of IPSC models is especially tantalizing when it comes to investigating the pathophysiology of schizophrenia. Multiple lines of evidence support the neurodevelopmental hypothesis of schizophrenia, which postulates that early developmental brain alterations lead to increased vulnerability for schizophrenia in adolescence and early adulthood. Until recently, investigation of the developmental origins of schizophrenia using human neurons has been all but impossible. However, with the discovery of IPSC models, it is now plausible that such faulty neurodevelopment could be recapitulated in vitro through neural progenitor cells (NPCs) and their differentiation to neurons.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Psychiatry editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.